First or Second Line Therapy
Drug | Drug Name | Drug Description |
---|---|---|
DB00112 | Bevacizumab | A monoclonal anti-vascular endothelial growth factor antibody used in combination with antineoplastic agents for the treatment of many types of cancer. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB01101 | Capecitabine | 1 | Terminated | 1 |
DB01259 | Lapatinib | 1 | Terminated | 1 |
DB00361 | Vinorelbine | 1 | Terminated | 1 |